Methods, dosage forms, and kits for administering ziprasidone without food

Details for Australian Patent Application No. 2009220925 (hide)

Owner Pfizer Inc.

Inventors Shah, Jaymin Chandrakant; Lukas, Timothy; Shamblin, Sheri L.; Lyon, David Keith; Curatolo, William John; Brett, William Caldwell; Craig, Christopher Donovan; Thombre, Avinash Govind; Friesen, Dwayne Thomas; Herbig, Scott Max

Agent Spruson & Ferguson

Pub. Number AU-A-2009220925

PCT Pub. Number WO2009/109844

Priority 61/034,947 07.03.08 US

Filing date 4 March 2009

Wipo publication date 11 September 2009

International Classifications

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/109844 Priority application(s): WO2009/109844

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220931-N-substitutedbenzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation

2009220914-Flexible platform shoe